Lymphoid interstitial pneumonia

Advocacy intelligence hub — real-time data for patient organizations

View full disease page →Search clinical trials →
Download CSV

At a Glance

Live from database

Regulatory Watchboard

4 events
Mar 20243D Evaluation of the Lip Support in a Full-arch Implant-supported Rehabilitations

Implantology Institute

TrialRECRUITING
Mar 2023Testing the Use of Investigational Drugs Atezolizumab and/or Bevacizumab With or Without Standard Chemotherapy in the Second-Line Treatment of Advanced-Stage Head and Neck Cancers

National Cancer Institute (NCI) — PHASE2, PHASE3

TrialACTIVE NOT RECRUITING
Oct 2019Durvalumab With Radiotherapy for Adjuvant Treatment of Intermediate Risk SCCHN

UNC Lineberger Comprehensive Cancer Center — PHASE2

TrialACTIVE NOT RECRUITING
Apr 2019Nivolumab and BMS986205 in Treating Patients With Stage II-IV Squamous Cell Cancer of the Head and Neck

Thomas Jefferson University — PHASE2

TrialACTIVE NOT RECRUITING

Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Financial Assistance

1 program

FINANCIAL LANDSCAPE SUMMARY

1

Total programs

1

Open now

Patient Assistance Programs1

Neutrexin

Medimmune Oncology, Inc.

OpenContact for details

View all support programs on disease page →

Approved Treatments

1 FDA-approved

Neutrexin

(Trimetrexate glucuronate)Orphan drugstandard

Medimmune Oncology, Inc.

View full treatment details on disease page →

Clinical Trial Landscape

3 active trials
2Phase 2
1Unknown
3Total recruiting
Search clinical trials for Lymphoid interstitial pneumonia

Recent News & Research

No recent news articles indexed yet for Lymphoid interstitial pneumonia.
Search PubMed for Lymphoid interstitial pneumonia

Browse all Lymphoid interstitial pneumonia news →

Specialist Network

Top 6 by expertise

View all Lymphoid interstitial pneumonia specialists →

Quick Actions